Ad26.COV2.S COVID-19 Vaccine Safety And Immunogenicity in Adolescents 16-17 Years of Age.

Autor: Ruiz-Guiñazú J; Janssen Research & Development, Beerse, Belgium., Le Gars M; Janssen Vaccines & Prevention Leiden, The Netherlands., Cárdenas V; Janssen Research & Development, Spring House, Pennsylvania, USA., Vaissière N; Janssen Research & Development, Beerse, Belgium., Sadoff J; Janssen Vaccines & Prevention Leiden, The Netherlands., Truyers C; Janssen Research & Development, Beerse, Belgium., Hendriks J; Janssen Vaccines & Prevention Leiden, The Netherlands., Scheper G; Janssen Vaccines & Prevention Leiden, The Netherlands., de Groot AM; Janssen Vaccines & Prevention Leiden, The Netherlands., Struyf F; Janssen Research & Development, Beerse, Belgium., Schuitemaker H; Janssen Vaccines & Prevention Leiden, The Netherlands., Douoguih M; Janssen Vaccines & Prevention Leiden, The Netherlands.

Publikováno v: Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2024 Nov 27; Vol. 13 (11), pp. 599-601.

Porous diamond foam with nanometric diamond grains using Bias Enhanced Nucleation on iridium

Autor: Vaissiere, N., Saada, S., Lee, K.H., Mermoux, M., Sennour, M., Arnault, J.C.

Publikováno v: In Diamond & Related Materials September 2016 68:23-27

Vinflunine–gemcitabine versus vinflunine–carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)

Autor: De Santis, M. ^*, Wiechno, P.J., Bellmunt, J., Lucas, C., Su, W.-C., Albiges, L., Lin, C.-C., Senkus-Konefka, E., Flechon, A., Mourey, L., Necchi, A., Loidl, W.C., Retz, M.M., Vaissière, N., Culine, S.

Publikováno v: In Annals of Oncology March 2016 27(3):449-454

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.